These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1422559)

  • 1. Cyclosporin-induced nephrotoxicity and hypertension.
    Sturrock ND; Lang CC; Struthers AD
    Br J Hosp Med; 1992 Oct 21-Nov 3; 48(8):483-5, 488-9. PubMed ID: 1422559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium channel blockers versus angiotensin-converting enzyme inhibitors: renal effects.
    Linas S
    Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):15-9. PubMed ID: 2220796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium antagonists and the kidney.
    Epstein M
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S18-24. PubMed ID: 7603073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of prostaglandin E1 analog misoprostol on chronic cyclosporin nephrotoxicity.
    John EG; Fornell LC; Radhakrishnan J; Anutrakulchai S; Jonasson O
    J Pediatr Surg; 1993 Nov; 28(11):1429-31; discussion 1432. PubMed ID: 8301454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of renin-angiotensin to calcium channel blockade in renal disease.
    Tikkanen I; Johnston CI
    Kidney Int Suppl; 1997 Dec; 63():S19-22. PubMed ID: 9407414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nephrotoxicity of cyclosporin. Clinical, physiopathological and histological aspects].
    Ben Hmida M; Deray G; Brillet G; Faucher C; Beaufils H; Jacobs C
    Ann Med Interne (Paris); 1991; 142(4):288-94. PubMed ID: 1929054
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of calcium channel antagonists on renal function in hypertensive heart transplant recipients.
    Bunke M; Ganzel B
    J Heart Lung Transplant; 1992; 11(6):1194-9. PubMed ID: 1457446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of renal disease--can it be reversed? The role of calcium channel blockers and angiotensin-converting enzyme inhibitors.
    Boner G
    Isr J Med Sci; 1996 Dec; 32(12):1217-21. PubMed ID: 9007157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic benefits of calcium channel blockers in cyclosporine-treated organ transplant recipients: blood pressure control and immunosuppression.
    Weir MR
    Am J Med; 1991 May; 90(5A):32S-36S. PubMed ID: 2039018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomized trials].
    Schillaci G; Vaudo G
    Ital Heart J Suppl; 2001 Jul; 2(7):799-802. PubMed ID: 11508301
    [No Abstract]   [Full Text] [Related]  

  • 12. Treating hypertension in the diabetic patient: therapeutic goals and the role of calcium channel blockers.
    Caldwell BV
    Clin Ther; 1993; 15(4):618-36; discussion 617. PubMed ID: 8221813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When hypertension and diabetes coexist: strategies for cardiorenal protection.
    Weber MA
    Postgrad Med; 2000 Oct; 108(5 Suppl):12-8. PubMed ID: 19667536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of cyclosporin A and amlodipine: blood cyclosporin A levels, hypertension and kidney function.
    Schrama YC; Koomans HA
    J Hypertens Suppl; 1998 Sep; 16(4):S33-8. PubMed ID: 9817190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Julius S
    Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hypertension in chronic renal insufficiency.
    Locatelli F; Manzoni C; Marcelli D
    J Nephrol; 1997; 10(4):220-3. PubMed ID: 9377731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin-induced hypertension in marmosets: a new model of hypertension sensitive to angiotensin-converting enzyme inhibition.
    Clozel JP; Fischli W
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):77-81. PubMed ID: 2475720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Calcium antagonist against hypertension. Arteriosclerosis controlled].
    MMW Fortschr Med; 2002 Oct; 144(42):63. PubMed ID: 12534002
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan.
    Sakamaki Y; Sasamura H; Ikeda S; Ikegami N; Saruta T
    Hypertens Res; 2006 May; 29(5):333-8. PubMed ID: 16832153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evidence-based usefulness of Ca antagonists and ACEIs and ARBs for the primary and secondary prevention of major cardiovascular and renal events in patients with hypertension].
    Fujino T; Hasebe N; Kikuchi K
    Clin Calcium; 2005 Oct; 15(10):1695-708. PubMed ID: 16199917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.